Moderna Adds Another 5% and Is Up 500% in 2026. Can MRNA Stock Continue the Melt-Up?24/7 Wall Street • 09/22/26
MRNA Hits 52-Week High: How Melanoma Study Results Keep Rally GoingZacks Investment Research • 09/22/26
Moderna will reveal the data for its mRNA cancer vaccine next month. Here's why it matters.Market Watch • 09/21/26
Moderna Surges 9% as Phase 3 Melanoma Data Wins Presidential Symposium Slot; Merck and BioNTech Edge Higher24/7 Wall Street • 09/21/26
Axsome Therapeutics vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 09/18/26
Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher24/7 Wall Street • 09/17/26
Is Cancer the Turnaround Moderna Has Been Looking for Post-COVID?Zacks Investment Research • 09/15/26
Moderna, Inc. (MRNA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
Moderna's COVID Vaccine Was a Historic Success. Could Its Cancer Vaccine Be Even Bigger?The Motley Fool • 09/14/26
How Cathie Wood's Fund Gave Us A Back Door To Moderna's BreakthroughInvestors Business Daily • 09/11/26
Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat24/7 Wall Street • 09/11/26
Congresswoman Bets on Elon Musk, Warren Buffett: Here's the Latest Stock TransactionsBenzinga • 09/10/26